Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases
Neurotherapeutics - United States
doi 10.1007/s13311-016-0486-7
Full Text
Open PDFAbstract
Available in full text
Date
October 18, 2016
Authors
Publisher
Springer Science and Business Media LLC